{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:58:32Z","timestamp":1791089912979,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jprot.2009.11.013","type":"journal-article","created":{"date-parts":[[2009,12,6]],"date-time":"2009-12-06T22:38:03Z","timestamp":1260139083000},"page":"1045-1060","source":"Crossref","is-referenced-by-count":27,"title":["Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders"],"prefix":"10.1016","volume":"73","author":[{"given":"David S.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Banha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Penque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Conrads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores J.","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine E.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2009.11.013_bib1","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/pmic.200600017","article-title":"Proteomic biomarkers for autoimmune disease","volume":"6","author":"Hueber","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.autrev.2005.07.003","article-title":"Autoimmunity in the era of genomics and proteomics","volume":"5","author":"Hershko","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jprot.2009.11.013_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.autrev.2007.01.009","article-title":"The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?","volume":"6","author":"Villalta","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jprot.2009.11.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2006.01863.x","article-title":"An update on Behcet's disease","volume":"21","author":"Kalayciyan","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jprot.2009.11.013_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14656566.5.2.317","article-title":"Managing the symptoms of Behcet's disease","volume":"5","author":"Evereklioglu","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jprot.2009.11.013_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/ar757","article-title":"Behcet's disease","volume":"5","author":"Hirohata","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jprot.2009.11.013_bib7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Behcet's disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1468-3083.2001.00251.x","article-title":"The multiple faces of Behcet's disease and its aetiological factors","volume":"15","author":"Onder","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jprot.2009.11.013_bib9","first-page":"1","article-title":"Epidemiology of Behcet's syndrome in Portugal","volume":"4","author":"Crespo","year":"2003","journal-title":"BD News"},{"key":"10.1016\/j.jprot.2009.11.013_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-006-0281-6","article-title":"Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells","volume":"27","author":"Pay","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jprot.2009.11.013_bib11","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s00018-003-2333-3","article-title":"Immunology and functional genomics of Behcet's disease","volume":"60","author":"Zierhut","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jprot.2009.11.013_bib12","first-page":"323","article-title":"Lymphocyte ceruloplasmin and Behcet's disease","volume":"31","author":"Oliveira","year":"2006","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.jprot.2009.11.013_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.1990.tb08095.x","article-title":"Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behcet's disease","volume":"79","author":"Niwa","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib14","first-page":"S1","article-title":"Behcet's disease and other autoinflammatory conditions: what's in a name?","volume":"23","author":"Yazici","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib15","first-page":"S79","article-title":"Autoinflammatory syndromes","volume":"24","author":"Galeazzi","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","article-title":"Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?","volume":"45","author":"Direskeneli","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jprot.2009.11.013_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568010053622894","article-title":"Behcet's disease as an autoinflammatory disorder","volume":"4","author":"Gul","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.jprot.2009.11.013_bib18","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","article-title":"Behcet's disease: from Hippocrates to the third millennium","volume":"87","author":"Verity","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jprot.2009.11.013_bib19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/bjo.78.12.927","article-title":"S-antigen specific T cell clones from a patient with Behcet's disease","volume":"78","author":"Yamamoto","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jprot.2009.11.013_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1076\/ocii.7.2.69.4018","article-title":"Behcet's disease and antibody titers to various heat-shock protein 60s","volume":"7","author":"Tanaka","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jprot.2009.11.013_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.2005.02760.x","article-title":"Alpha tropomyosin as a self-antigen in patients with Behcet's disease","volume":"140","author":"Mahesh","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9","article-title":"Identification of alpha-tropomyosin as a target self-antigen in Behcet's syndrome","volume":"32","author":"Mor","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.exer.2007.01.003","article-title":"Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease","volume":"84","author":"Okunuki","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000018122","article-title":"Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behcet's disease","volume":"198","author":"Orem","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jprot.2009.11.013_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1348-0421.2005.tb03640.x","article-title":"Autoantibodies to peroxiredoxin I and IV in patients with systemic autoimmune diseases","volume":"49","author":"Karasawa","year":"2005","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib26","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jprot.2009.11.013_bib27","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1021\/pr800279m","article-title":"MALDI-TOF\/TOF-MS reveals elevated serum haptoglobin and amyloid A in Behcet's disease","volume":"7","author":"Mao","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.humimm.2006.08.294","article-title":"Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides","volume":"67","author":"Gebreselassie","year":"2006","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/38.6.529","article-title":"Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement","volume":"38","author":"Ames","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jprot.2009.11.013_bib30","series-title":"Biomarkers for Beh\u00e7et's disease: in a quest for the holy grail using proteomics tools","first-page":"40","author":"Banha","year":"2009"},{"key":"10.1016\/j.jprot.2009.11.013_bib31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.pathmechdis.3.121806.151419","article-title":"Applications of proteomics to lab diagnosis","volume":"3","author":"Chaerkady","year":"2008","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.jprot.2009.11.013_bib32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nbt.1546","article-title":"Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma","volume":"27","author":"Addona","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jprot.2009.11.013_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1586\/14789450.2.5.693","article-title":"Cancer proteomics: many technologies, one goal","volume":"2","author":"Conrads","year":"2005","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib34","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1078-0432.CCR-07-1497","article-title":"Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression","volume":"14","author":"Patel","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ymeth.2004.08.018","article-title":"The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications","volume":"35","author":"Kirkpatrick","year":"2005","journal-title":"Methods"},{"key":"10.1016\/j.jprot.2009.11.013_bib36","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1074\/mcp.T500039-MCP200","article-title":"Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry","volume":"5","author":"Ono","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib37","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1021\/pr049963d","article-title":"Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-MS\/MS using protein cleavage and isotope dilution mass spectrometry","volume":"3","author":"Barnidge","year":"2004","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib38","first-page":"1975","article-title":"Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register","volume":"23","author":"Symmons","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib39","first-page":"663","article-title":"Growth patterns in juvenile rheumatoid arthritis","volume":"21","author":"Liem","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib40","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib41","first-page":"386","article-title":"Prognostic factors in juvenile rheumatoid arthritis: a case\u2013control study revealing early predictors and outcome after 14.9years","volume":"30","author":"Flato","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1001\/jama.294.13.1671","article-title":"Medical treatment of juvenile idiopathic arthritis","volume":"294","author":"Hashkes","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jprot.2009.11.013_bib43","first-page":"366","article-title":"Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy","volume":"25","author":"Flato","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib44","first-page":"832","article-title":"Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis","volume":"30","author":"Oen","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib45","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.172.10.6435","article-title":"CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis","volume":"172","author":"de Kleer","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jprot.2009.11.013_bib46","first-page":"2451","article-title":"Induction of invasive and degradative phenotype in normal synovial fibroblasts exposed to synovial fluid from patients with juvenile rheumatoid arthritis: role of mononuclear cell population","volume":"24","author":"Khalkhali-Ellis","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib47","first-page":"271","article-title":"Toward an understanding of the long-term outcome of juvenile idiopathic arthritis","volume":"22","author":"Ravelli","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib48","first-page":"1531","article-title":"Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis","volume":"29","author":"Huemer","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib49","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F","article-title":"Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis","volume":"43","author":"Woo","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jprot.2009.11.013_bib50","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/pr060129t","article-title":"Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis","volume":"5","author":"Gibson","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib51","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1203\/PDR.0b013e31819e4305","article-title":"Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis","volume":"65","author":"Suzuki","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib52","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1007\/s00467-007-0608-x","article-title":"Identification of a urinary proteomic signature for lupus nephritis in children","volume":"22","author":"Suzuki","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jprot.2009.11.013_bib53","doi-asserted-by":"crossref","first-page":"R563","DOI":"10.1186\/ar1443","article-title":"Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production?","volume":"6","author":"Bresnihan","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jprot.2009.11.013_bib54","doi-asserted-by":"crossref","first-page":"R746","DOI":"10.1186\/ar1723","article-title":"Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy","volume":"7","author":"Miyamae","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jprot.2009.11.013_bib55","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1542\/peds.113.6.1820","article-title":"Cushing's syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patients","volume":"113","author":"Kumar","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jprot.2009.11.013_bib56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/keh401","article-title":"Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis","volume":"44","author":"Dolezalova","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jprot.2009.11.013_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/prca.200800073","article-title":"Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins","volume":"3","author":"Low","year":"2009","journal-title":"Proteomics \u2014 Clin Applic"},{"key":"10.1016\/j.jprot.2009.11.013_bib58","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar2478","article-title":"Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis","volume":"10","author":"Zhao","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jprot.2009.11.013_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/prca.200700044","article-title":"The human synovial fluid proteome: a key factor in the pathology of joint disease","volume":"1","author":"Gibson","year":"2007","journal-title":"Proteomics \u2014 Clin Applic"},{"key":"10.1016\/j.jprot.2009.11.013_bib60","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jprot.2009.01.022","article-title":"Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis\u2014proteomic patterns of joint inflammation in early stage disease","volume":"72","author":"Gibson","year":"2009","journal-title":"J Proteomics"},{"issue":"10","key":"10.1016\/j.jprot.2009.11.013_bib61","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/S0021-9258(19)41496-8","article-title":"High resolution two-dimensional electrophoresis of proteins","volume":"250","author":"O'Farrell","year":"1975","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.jprot.2009.11.013_bib62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00216-005-3126-3","article-title":"The development of the DIGE system: 2D fluorescence difference gel analysis technology","volume":"382","author":"Marouga","year":"2005","journal-title":"Anal Bioanal Chem"},{"issue":"11","key":"10.1016\/j.jprot.2009.11.013_bib63","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/elps.1150181133","article-title":"Difference gel electrophoresis: a single gel method for detecting changes in protein extracts","volume":"18","author":"Unlu","year":"1997","journal-title":"Electrophoresis"},{"issue":"3","key":"10.1016\/j.jprot.2009.11.013_bib64","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/1615-9861(200103)1:3<377::AID-PROT377>3.0.CO;2-6","article-title":"Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology","volume":"1","author":"Tonge","year":"2001","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.jprot.2009.11.013_bib65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pmic.200390006","article-title":"A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard","volume":"3","author":"Alban","year":"2003","journal-title":"Proteomics"},{"issue":"3","key":"10.1016\/j.jprot.2009.11.013_bib66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/pr050405o","article-title":"Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF\/TOF","volume":"5","author":"Wu","year":"2006","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib67","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1096\/fj.02-0019fje","article-title":"Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring","volume":"16","author":"de Kleijn","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.jprot.2009.11.013_bib68","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1083\/jcb.136.6.1375","article-title":"Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization","volume":"136","author":"Carlevaro","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jprot.2009.11.013_bib69","doi-asserted-by":"crossref","first-page":"46551","DOI":"10.1074\/jbc.M405284200","article-title":"Cellular membrane type-1 matrix metalloproteinase (MT1-MMP) cleaves C3b, an essential component of the complement system","volume":"279","author":"Rozanov","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jprot.2009.11.013_bib70","first-page":"397","article-title":"Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis","volume":"91","author":"Berkowicz","year":"1983","journal-title":"Acta Pathol Microbiol Immunol Scand C"},{"key":"10.1016\/j.jprot.2009.11.013_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(01)00325-8","article-title":"Protein and antibody arrays and their medical applications","volume":"250","author":"Cahill","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jprot.2009.11.013_bib72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pmic.200401293","article-title":"Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip","volume":"6","author":"Horn","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib73","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1074\/mcp.T500004-MCP200","article-title":"Profiling of alopecia areata autoantigens based on protein microarray technology","volume":"4","author":"Lueking","year":"2005","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib74","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1074\/mcp.R600010-MCP200","article-title":"Tumor-associated antigen arrays for the serological diagnosis of cancer","volume":"5","author":"Casiano","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib75","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.CIR.80.3.564","article-title":"Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975\u20131984","volume":"80","author":"Codd","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib76","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jacc.2004.04.055","article-title":"Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy","volume":"44","author":"Staudt","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2009.11.013_bib77","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/01.CIR.89.5.2421","article-title":"Mechanisms of immune-mediated myocyte injury","volume":"89","author":"Barry","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/bbrc.1999.0761","article-title":"Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients","volume":"259","author":"Warraich","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jprot.2009.11.013_bib79","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1067\/mhj.2002.124406","article-title":"Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates","volume":"143","author":"Warraich","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jprot.2009.11.013_bib80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916930008994101","article-title":"Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy","volume":"32","author":"Omerovic","year":"2000","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jprot.2009.11.013_bib81","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1161\/01.CIR.89.6.2760","article-title":"Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect","volume":"89","author":"Magnusson","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib82","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1172\/JCI116416","article-title":"Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy","volume":"91","author":"Fu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jprot.2009.11.013_bib83","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.81.3.959","article-title":"Antibodies to ADP-ATP carrier\u2013an autoantigen in myocarditis and dilated cardiomyopathy\u2013impair cardiac function","volume":"81","author":"Schulze","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib84","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.RES.64.2.179","article-title":"Antibodies to the ADP\/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo","volume":"64","author":"Schulze","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib85","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0735-1097(93)90546-D","article-title":"Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting","volume":"22","author":"Latif","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2009.11.013_bib86","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.85.5.1734","article-title":"Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy","volume":"85","author":"Caforio","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib87","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.CIR.0000036746.49449.64","article-title":"Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy","volume":"106","author":"Staudt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jprot.2009.11.013_bib88","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","article-title":"Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice","volume":"291","author":"Nishimura","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jprot.2009.11.013_bib89","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0002-8703(91)90766-B","article-title":"Effect of antireceptor antibodies in dilated cardiomyopathy on the cycling of cardiac beta receptors","volume":"122","author":"Limas","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.jprot.2009.11.013_bib90","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1093\/nar\/26.21.5007","article-title":"A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library","volume":"26","author":"Bussow","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib91","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1021\/ac034260l","article-title":"3D protein microarrays: performing multiplex immunoassays on a single chip","volume":"75","author":"Angenendt","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.jprot.2009.11.013_bib92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0003-2697(02)00257-9","article-title":"Toward optimized antibody microarrays: a comparison of current microarray support materials","volume":"309","author":"Angenendt","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jprot.2009.11.013_bib93","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1074\/mcp.T300001-MCP200","article-title":"A nonredundant human protein chip for antibody screening and serum profiling","volume":"2","author":"Lueking","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.jprot.2009.11.013_bib94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1388-1981(02)00270-6","article-title":"Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure","volume":"1584","author":"Yu","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jprot.2009.11.013_bib95","first-page":"H1113","article-title":"Role of Ca(2+)-independent PKC in alpha 1-adrenoceptor-mediated inotropic responses of neonatal rat hearts","volume":"273","author":"Deng","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jprot.2009.11.013_bib96","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0008-6363(95)00059-3","article-title":"Myocardial Ca(2+)- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies","volume":"30","author":"O'Brien","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib97","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/01.RES.75.3.443","article-title":"Gene expression of the cardiac Na(+)\u2013Ca2+ exchanger in end-stage human heart failure","volume":"75","author":"Studer","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib98","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF02054252","article-title":"Autoantibodies in systemic lupus erythematosus and normal subjects","volume":"5","author":"Pateraki","year":"1986","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jprot.2009.11.013_bib99","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0735-1097(00)00568-4","article-title":"Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study","volume":"35","author":"Felix","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jprot.2009.11.013_bib100","series-title":"Paper presented at NCI workshop on Ductal Carcinoma in Situ, San Francisco","article-title":"Statistical issues in investigating prognostic and predictive markers for DCIS","author":"Dignam","year":"2007"},{"key":"10.1016\/j.jprot.2009.11.013_bib101","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.jprot.2009.11.013_bib102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jprot.2009.11.013_bib103","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1191\/096228098678080061","article-title":"Sample size calculations in studies of test accuracy","volume":"7","author":"Obuchowski","year":"1998","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.jprot.2009.11.013_bib104","series-title":"Paper 211 30th SAS User Group International Conference","article-title":"Statistical methods in diagnostic medicine using SAS software","author":"Mandraekar","year":"2005"},{"key":"10.1016\/j.jprot.2009.11.013_bib105","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.csda.2005.03.011","article-title":"Using principal components for estimating logistic regression with high-dimensional multicollinear data","volume":"50","author":"Aguilera","year":"2006","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/j.jprot.2009.11.013_bib106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14622416.5.6.709","article-title":"Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective","volume":"5","author":"Feng","year":"2004","journal-title":"Pharmacogenomics"}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391909003467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391909003467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T13:49:49Z","timestamp":1634305789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391909003467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1874391909003467"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2009.11.013","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}